معرفی
Sanjeevini Babu Reddiar is a Research Fellow at Monash University's Department of Drug Delivery Disposition & Dynamics. Her work focuses on advancing drug delivery systems, particularly in lymphatic biology and peptide-based therapeutics. She contributes to UN Sustainable Development Goals through research addressing healthcare innovation and non-communicable diseases.
- Expertise: Lymphatic drug transport, neuroinflammation modulation, and peptide pharmacokinetics
Her research explores mechanisms like intestinal lymphatic absorption barriers, radiolabeled peptide biodistribution, and Kv1.3 potassium channel inhibition in neuroinflammatory conditions. Collaborations span institutions globally, emphasizing translational pharmacology and biomaterials.
Key publications include a 2024 review on intestinal lymphatic drug delivery and multiple studies on Kv1.3-blocking peptides' neurotherapeutic potential. Her work is frequently open-access, highlighting commitment to knowledge sharing.
